IVIg vs different infusion regimens of IVIG
Need for extra treatment · people undergoing initial treatment for KD
Primary treatment with intravenous immunoglobulin (IVIG) may leads to lower need for additional treatment (up to 6 months) compared with different infusion regimens of IVIG (low certainty).
1 finding from 1 review
- Intravenous immunoglobulin for the treatment of Kawasaki disease 2023 · Cochrane Headline outcomes onlyOR 0.29 [0.1, 0.88]4 studies · 1125 participantsLow